Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > GRPH Graphite Bio > Detailed Quotes

GRPH Graphite Bio

Watchlist
2.070
-0.110-5.05%
Close  02/03 16:00 ET
2.0700.0000.00%
Post Mkt Price 02/03 16:35 ET
High
2.205
Open
2.150
Turnover
116.78K
Low
2.020
Pre Close
2.180
Volume
55.49K
Market Cap
120.38M
P/E(TTM)
Loss
52wk High
11.300
Shares
58.15M
P/E(Static)
Loss
52wk Low
1.590
Float Cap
39.74M
Bid/Ask %
71.43%
Historical High
34.000
Shs Float
19.20M
Volume Ratio
0.40
Historical Low
1.590
Dividend TTM
--
Div Yield TTM
--
P/B
0.38
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.29%
Amplitude
8.49%
Avg Price
2.104
Lot Size
1
Float Cap
39.74M
Bid/Ask %
71.43%
Historical High
34.000
Shs Float
19.20M
Volume Ratio
0.40
Historical Low
1.590
Dividend TTM
--
P/B
0.38
Dividend LFY
--
Turnover Ratio
0.29%
Amplitude
8.49%
Avg Price
2.104
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Graphite Bio, Inc. operates as a clinical-stage gene editing company. It focuses on therapies that harness targeted gene integration to treat or cure serious diseases. The company was founded by Matthew Porteus and Maria Grazia Roncarolo in June 2017 and is headquartered in South San Francisco, CA.
CEO: Dr. Joshua Lehrer-Graiwer, M.D.
Market: NASDAQ
Listing Date: 06/25/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist